Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,722,222
-
Share change
-
-2,537,036
-
Total reported value
-
$10,268,003
-
Price per share
-
$1.33
-
Number of holders
-
44
-
Value change
-
-$4,548,056
-
Number of buys
-
24
-
Number of sells
-
41
Institutional Holders of AEVI GENOMIC MEDICINE INC - COM (GNMX) as of Q2 2017
As of 30 Jun 2017,
AEVI GENOMIC MEDICINE INC - COM (GNMX) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,722,222 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, 22NW, LP, Birchview Capital, LP, and ELEMENT CAPITAL MANAGEMENT LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.